The prevalence of latex allergy varies greatly depending on the population studied and the methods used to detect sensitization. Subjects considered to be at high risk for latex allergy are rubber industry workers, children with spina bifida and urological abnormalities, children undergoing multiple surgical procedures and with urinary catheterization, health care workers and people with food allergy (latex fruit syndrome). In this paper we report a review of latex proteins, the symptoms of latex allergy, diagnosis and management in subjects with latex allergy.
Many products derived from the latex of Hevea brasiliensis (rubber tree) contain allergenic latex proteins. Sensitization occurs by direct contact with latex products or by inhalation of airborne latex particles. Subjects commonly considered to be at high risk for latex allergy are rubber industry workers, children with spina bifida or urological abnormalities, children undergoing multiple surgical procedures and with urinary catheterization and health care workers. In addition, atopic patients are reported to be more susceptible to latex allergy than non atopic individuals. Latex products can trigger immediate, IgE-mediated (urticaria, asthma, rhinitis, conjunctivitis, orbit edema, angioedema, lip edema, anaphylaxis) and delayed, type IV (contact dermatitis) allergic reactions (1,2,3).
LATEX PROTEINS
Natural latex is a milky sap produced by many different plants. The latex that is used industrially is derived almost exclusively from the rubber tree, Hevea brasiliensis, which belongs to the Euphorbiaceous family (4). This sap is processed to make many rubber products used in the home as well as in workplaces, such as balloons, gloves, rubber toys, pacifiers, baby-bottle nipples, rubber bands, adhesive tape, bandages, diapers, sanitary pads, condoms, etc. In addition, many medical and dental supplies containing latex include gloves, urinary catheters, dental dams and material used to fill root canals, as well as tourniquets and equipment for resuscitation. Latex is composed of spherical poly-isoprene droplets coated with a layer of water-soluble proteins. It contains variable amounts of water-soluble proteins that can be recognized as allergens by the human immune system (5) . Latex concentrate contains about I% total protein, a small fraction of which remains in the resulting manufactured product as residual extractable protein. This protein material binds to a specific human IgE antibody and has been implicated in severe allergic reactions. By contrast, dry rubber contains very little protein and is therefore much less immunogenic than latex sap. Latex gloves cause both allergic and non-allergic symptoms to different rubber products. The allergen that is the actual substance that induces the allergy is a protein constituent ofthe latex. Several allergens have been cloned and others partially characterized (Hev b 1-14) (Table I) (6) . Hev b I and Hev b 3 are major allergens in children with spina bifida and urological congenital anomalies, whereas Hev b 2 and Ii, BERNARDINI ET AI.. Hev b 4 ['1'C more important for health care workers with latex allergy (7) .
HISTORY AND GLOBAL PREVALENCE OF LATEX ALLERGY
Latex allergy was first reported by Stem in 1927; he described a patient with a severe generalized urticaria reaction to a latex prosthesis. Almost 50 years later, contact urticaria to latex gloves was reported by Nutter (8) . During the 1980s and 90s, a latex allergy epidemic broke out in industrialized countries, particularly in subjects exposed to latex allergens. During the last decade, there was a decrease in clinical manifestations to latex products due to avoiding exposure to latex products and using latexfree products. Nevertheless, natural rubber latex products are still used, alone or combined with other substances, in the manufacturing of more than 40,000 different objects for technical, professional and everyday-life use. The prevalence of latex allergy varies greatly depending on the population studied and the methods used to detect sensitization. Depending on diagnosis methodology, the prevalence of latex sensitivity among health care workers varied between 2.9% and 17%. Approximately 70% of adverse events to latex reported in the FDA's Med Watch database involve health care workers; sensitization prevalence is 18%-37%. It is 34% and 67% in individuals who have undergone multiple surgical procedures and in children with neural defects, respectively (9, 10, II, 12, 13).
DEFINITION OF LATEX ALLERGY
Latex allergy is characterized by the presence of latex specific IgE antibody associated with symptoms consistent with IgE-mediated reactions to latex-containing objects (1O, 11).
Classification oflatex reactions
Systemic reaction: A type I hypersensitivity reaction involving specific IgE to Hev latex proteins. Clinical manifestations usually include urticaria, rhinitis, conjunctivitis, asthma and anaphylaxis. Some sensitized individuals suffered oral allergic syndrome and/or systemic allergic reactions to one or more vegetables (latex fruit syndrome) (e.g., kiwis, bananas, pineapples, avocados, peaches, passion fruit, mangos, chestnuts, potatoes, buckwheat, dill, figs, carrots, sweet peppers, tomatoes, oregano and sage) (I 0, II, 12).
Contact dermatitis:
A delayed type IV hypersensitivity reaction consisting of an eczematous reaction starting 24-48 h after repeated skin or mucosal contact with additives used during rubber production. This is a T cell-mediated, non-life-threatening reaction. It may, however, predispose the individual to IgE-mediated systemic reactions (10, II ).
Clinical non-immune-mediated reaction: Irritant
dermatitis resulting from a mild irritating effect of the powder in latex gloves. This is the most frequent reaction, limited to the contact area and is characterized by itching, irritation and blistering at the site of contact (10, II).
Signs and symptoms oflatex allergy
Latex hypersensitivity reactions can affect the skin, eyes, nose and lungs (2, 10, 11) . Skin manifestations include itching, swelling, redness and later, an eczema (2, 10, 11). Respiratory involvement consists of sneezing and wheezing(2, 10, II). The eyes may water and itch (14) .
A type IV or delayed (cell mediated) hypersensitivity reaction to latex can also occur with latex gloves (allergic contact dermatitis of the hands). Metramethylthiuram (added to latex as an accelerator) and mercaptobenzothiazole (added to latex as an antioxidant) could cause a type IV hypersensitivity.
Some researchers have shown that endotoxins found in powdered gloves and bacterial contamination (particularly in non-sterile latex gloves) can lead to various clinical features ranging from skin erythema and asthma to fever, malaise and shock. In this situation, subjects may have clinical symptoms and negative serological or skin tests to latex.
Immediate reactions can be life-threatening when blood pressure drops, airways block and the throat closes. These symptoms can be exacerbated in certain people when specific foods (with a cross antigenicity and a cross allergy) (12) are ingested.
Allergy to latex rubber involves sensitization to multiple constituent proteins (Table I) . Therefore, different groups of patients respond to specific latex proteins in various ways. These groups of proteins are found in many products including, but not limited to, certain tree pollens, certain plants, and (most commonly) fresh fruit (12) . Produce (fruits and vegetables) that commonly cause hypersensitivity when associated with latex proteins are avocados, bananas, celery, chestnuts and pears. Hypersensitivity is less common with apricots, buckwheat, cherries, figs, grapes, kiwis, mangos, melons, nectarines, oranges, papaya, passion fruit, peaches, peanuts, pineapples, plums, potatoes, tomatoes and walnuts (15) . The problem manifests itself in two ways: the fruit allergy triggers previously undiagnosed recognition of the latex allergy or after years of latex exposure and latex sensitivity, the person develops fruit allergies. Whether this dual latex-fruit sensitivity is determined by common antigens or crossreacting antigens has yet to be completely determined (6, 12, 15 (16) . Glove-use tests and nasal, mucosal, conjunctival and bronchial provocation tests might also be performed to arrive at a diagnosis of latex allergy (17) . The presence of specific serum IgE to latex is a marker of sensitization without correlation with latex symptoms (18) . In atopic patients who frequently have very high levels of total IgE, non-specific binding to the allergen can cause false positive results.
In vitro tests
Various immunoassays are currently available such as CAP RAST FlEA (Phannacia UpJohn), microplate AlaSTAT (Diagnostics Products) and HY-TEC-EIA (HYTEC) (19) . Their specificities (rate of true negative) range from 80%-87% and their sensitivities (rate of true positive) range from 53%-97% (19) . Actually it is possible to identify various allergenic components oflatex (component resolved diagnosis, ImmunoCAP Allergen Components) (20, 21) .
In vivo tests
An SPT with latex extracts is sensitive, specific and rapid. Significant variability in the allergen content of extracts continues to limit the SPT reproducibility. Diagnostic sensitivity of different latex extracts for SPTs could differ; some authors demonstrated that ammoniated latex extract shows a higher sensitivity as compared to non-ammoniated products (22) .
If clinical history, SPT to latex and determination of specific serum IgE to latex are not sufficient to arrive at a correct diagnosis of latex allergy, in vivo provocation tests may be used (17) , which may include natural environmental exposure, glove use and rubbing tests and nasal, mucosal, conjunctival and bronchial provocation tests (17) .
A test with glove fingertips may be performed. A fingertip is cut from a latex glove, dampened with water and placed on the person's finger for 15 minutes. A positive test results in urticaria with itching or erythema. If no reaction occurs, placing an entire dampened glove on the hand for 15 minutes or until a reaction occurs is considered to be safe. After the glove use test, you can perform a rubbing test. The glove is removed from the hand and the face is rubbed with the external and internal parts of the glove (12) . Local (itching, erythema.wheals) and general symptoms (rhinitis, asthma) are evaluated for at least 2 hours. A symptom score is used (12) .
The induction oflatex allergy can occur after exposure of mucous membranes to latex, for instance the mouth, vagina or rectum; but sensitization can also occur through the skin, by inhalation or by internal exposure. Moreover, medical devices such as anesthetic masks, condom catheters, ileostomy bags, balloon catheters used for enemas and latex gloves can induce latex symptoms. Latex gloves are particularly prone to induce allergy when they contain starch powder, which has the effect of concentrating the protein. Latex allergy falls mostly into the category of immediate (type I) reactions that come on within minutes of exposure to the latex protein. The allergic reaction is mediated by the release ofinflammatory substances from dermal mast cells triggered by the linking ofIgE molecules to the surface of the cells.
MANAGEMENT
There are two aspects to management -for staff and for patients. For staff, the most important aspect is the use of non-latex gloves (gloves made of vinyl, stretch vinyl, thermoplastic elastomeric or nitrile). A study comparing the barrier function and handling characteristics of these gloves demonstrated that nitrile may be the most suitable alternative to latex. Conversely, Yunginger and coworkers suggested that substitution of non-latex gloves will in all probability involve some loss of barrier function (23) .
For patients, the situation is more complicated because during ward management, or particularly during surgery, they are likely to be exposed to latex-containing materials from virtually every side and often through many orifices. It is therefore important to identify patients at high risk of developing serious reactions to latex especially during operative procedures. Kelly and coworkers showed that regarding children with spina bifida who must have operations, factors such as atopy, medical history of immediate contact allergy to latex, food allergy, IgE greater than 84 IU, or nine or more prior surgical procedures can identify those with highest risk of anaphylactic reactions (24) . Other studies reported different results (I, 25) .
Patients who are known to be allergic should avoid any product that might contain latex until the latex content is determined by contacting the manufacturer. Even products labeled "safe latex" (which indicates lower proportions of natural latex) can cause latex allergy. There is no safe latex for latex allergy sufferers. Type I reactions are treated just like any other systemic allergic reaction with epinephrine, antihistamines (H I antagonists), systemic corticosteroids and H2 blockers. Type IV reactions can be treated with topical steroids along with patient education to avoid further exposure (26) .
Immunotherapy
As latex allergy is an IgE-mediated disease, various desensitization regimes have been tried with moderate success. Sublingual immunotherapy with latex allergen have been reported to be successful in patients with clinical latex allergy (12, 27, 28, 29) .
Programming and education
Education is very important in controlling allergic reactions and starts with the latex-sensitive individual. The person who is diagnosed with latex sensitivity needs to be educated on the condition and should understand prevention and avoidance techniques. The second level of education is for the individual to notify his or her employer of the condition so that latex-free alternatives can be made available. The third level ofeducation involves employers, who must establish policies and procedures to ensure the safety of the latex-sensitive person. All other employees must be informed of practices to prevent exposure of the sensitive individual to latex and to recognize the signs and symptoms of an allergic reaction (30) .
Pre-operative assessment
A history of pre-operative symptoms suggestive of latex allergy is present in approximately 25% of patients who develop intra-operative latex-related anaphylaxis.
Pre-operative testing
Subjects at high risk of latex allergy and/or patients Table I . Latex allergens with suspected latex allergy require testing before a surgical procedure. If the clinical history is positive or equivocal, the patient should be referred for testing before the surgical procedure and surgery should proceed only in an emergency. In the preoperative situation, it is particularly important to exclude IgE-mediated sensitivity. Current tests have a sensitivity ofapproximately 75-90%; skin prick testing may be more sensitive than blood tests for specific IgE. It may be appropriate to proceed to challenge testing in some patients.
Perioperative precautions
If latex allergy is diagnosed pre-operatively, avoidance is mandatory.
Care should be taken to avoid introducing additional, unrelated hazards when latex precautions are implemented in the operating room.
Latex allergy should be recorded in the casenotes and on the patient's wrist bracelet.
The surgical team and the nursing and anesthetic support teams should be alerted.
There is no evidence that premedication with an anti-histamine or steroid is helpful.
The operating room should be prepared the night before to avoid the release of latex particles and the patient should be scheduled first on the list.
Absolute use of synthetic gloves during anesthesia, surgery and postoperative care.
The anesthetic and surgical areas must have only latex free products. Serum tryptase is the only helpful blood test required at the time of the reaction to confirm anaphylaxis. Two timed blood samples (5 mL clotted) should be taken: one immediately after resuscitation and one at 1-2 h. If this is missed, a timed sample may be taken up to 6 h, although this may be less helpful. A baseline sample should also be taken at 24 h or later by the investigating allergist (30) .
Postoperative investigation ofpossible latex anaphylaxis
If skin testing and specific IgE testing is negative or equivocal in the presence of a suggestive history, it may be appropriate for the patient to proceed to a latex provocation test. Patch testing is helpful in the diagnosis of delayed (type IV) hypersensitivity to latex.
Hospital latex-allergy policy
Hospitals should make policy and purchasing decisions to minimize latex exposure in their institutions and to protect sensitized patients and employees, as well as to reduce the risk of primary sensitization. This requires eliminating powdered latex examination gloves and substituting less allergenic latex gloves. This strategy has been shown to reduce natural rubber latex aeroallergen, primary sensitization and incidence of asthma.
